Advertisements


Sage Therapeutics, Shionogi partner on development of SAGE-217 in Asia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Why Sage Therapeutics Is Booming

Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S.........»»

Category: blogSource: 247wallstJun 12th, 2018

Sage Therapeutics Continues To Push Forward With Multiple Positive CNS Studies

Sage Therapeutics Continues To Push Forward With Multiple Positive CNS Studies.....»»

Category: topSource: seekingalphaJan 8th, 2019

Sage Therapeutics"s stock shoots higher after postpartum depression treatment"s positive trial results

Shares of Sage Therapeutics Inc. shot up 44% in active early-afternoon.....»»

Category: topSource: marketwatchJan 7th, 2019

Axsome, Sage Therapeutics Move On Positive Results From Depression Drug Studies

Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) and SAGE Therapeutics Inc (NASDAQ: SAGE) were¬†moving sharp read more.....»»

Category: blogSource: benzingaJan 7th, 2019

Pill for postpartum depression by Cambridge"s Sage succeeds in late-stage trial

Sage Therapeutics, one of Cambridge's largest biotech firms, today reported that its pill to treat postpartum depression appears to have succeeded in a late-stage trial. In a study of 151 women suffering from the condition, those who were given ora.....»»

Category: topSource: bizjournalsJan 7th, 2019

Sage Therapeutics: SAGE-217 meets primary, secondary endpoints in Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Sage Therapeutics reiterated as buy at SunTrust Robinson Humphrey

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 31st, 2018

Oversold Conditions For Sage Therapeutics (SAGE)

Dividend Channel.....»»

Category: topSource: redinewsDec 19th, 2018

Sage Therapeutics files automatic mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 18th, 2018

Sage Therapeutics initiated with an Outperform at Wolfe Research

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

GW Pharma, Sage Therapeutics named Top Picks in biotech at Stifel

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 14th, 2018

JMP boosts Marinus target to $29, sees "clear" competitor to Sage Therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 10th, 2018

Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE)

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual i.....»»

Category: topSource: insidermonkeyDec 10th, 2018

Sage Therapeutics receives notification of PDUFA extension for ZULRESSO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 20th, 2018

Sage Therapeutics initiated with an Underperform at Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Sage Therapeutics (SAGE) CEO Jeff Jonas on Q3 2018 Results - Earnings Call Transcript

Sage Therapeutics (SAGE) CEO Jeff Jonas on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 6th, 2018

Sage Therapeutics shares halted premarket for news pending

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchNov 2nd, 2018

Sage Therapeutics shares halted ahead of regulatory meeting on post-partum treatment

Sage Therapeutics Inc. said Friday its stock has been halted pr.....»»

Category: topSource: marketwatchNov 2nd, 2018

Stifel confident in approval of Sage Therapeutics" brexanolone ahead of AdComm

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Sage Therapeutics started at outperform with $170 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 11th, 2018